Clinical trials
Adenocarcinoma trials in the Netherlands
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
35 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2005 | 1 |
| 2006 | 2 |
| 2008 | 1 |
| 2010 | 3 |
| 2011 | 1 |
| 2014 | 2 |
| 2015 | 2 |
| 2016 | 4 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 1 |
| 2025 | 5 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 18 |
| Recruiting | 8 |
| Active, not recruiting | 4 |
| Terminated | 4 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 3 |
| Abbott | 2 |
| Astellas Pharma Global Development, Inc. | 2 |
| AstraZeneca | 2 |
| Hoffmann-La Roche | 2 |
| University Medical Center Groningen | 2 |
| Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 1 |
| Amsterdam UMC, location VUmc | 1 |
| Ariad Pharmaceuticals | 1 |
| Blueprint Medicines Corporation | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Adenocarcinoma | 35 |
| Neoplasms | 15 |
| Carcinoma, Non-Small-Cell Lung | 11 |
| Carcinoma | 9 |
| Neoplasms by Site | 8 |
| Lung Neoplasms | 7 |
| Neoplasms by Histologic Type | 7 |
| Carcinoma, Squamous Cell | 5 |
| Digestive System Neoplasms | 5 |
| Carcinoma, Bronchogenic | 4 |
Trials
Showing 26 to 35 of 35. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.